by Antonio Regalado on (#5CSYZ)
Covid vaccines reprogrammed to aim at emerging new strains of the virus could reach the market quickly, without going through large clinical trials, according to officials at Moderna Therapeutics and the US government. As researchers identify mutated versions of the coronavirus that causes covid-19, there’s concern that the germ could evade approved vaccines and new…